Brief: IGM Biosciences Announces Strategic Pivot To Focus Exclusively On Autoimmunity
30/09/2024 21:39
Sept 30 (Reuters) - IGM Biosciences Inc IGMS.O :
* IGM BIOSCIENCES ANNOUNCES STRATEGIC PIVOT TO FOCUS
EXCLUSIVELY
ON AUTOIMMUNITY
* IGM BIOSCIENCES INC - MARY BETH HARLER APPOINTED AS CEO
AND TO
BOARD
* IGM BIOSCIENCES INC - COMPANY EXTENDS CASH RUNWAY INTO
2027
* IGM BIOSCIENCES INC - TO MINIMIZE SPENDING ON ONCOLOGY
CANDIDATES
* IGM BIOSCIENCES INC - STRATEGIC PIVOT TO DEVELOPMENT OF T
CELL
ENGAGING IGM ANTIBODIES FOR TREATMENT OF AUTOIMMUNE DISEASES
* IGM BIOSCIENCES INC - FRED SCHWARZER AND BRUCE KEYT TO
STEP DOWN
FROM CURRENT ROLES
Source text for Eikon: ID:nGNX1KFP5F
Further company coverage: IGMS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary